A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland

Obesity or Overweight Clinical Trial

Official title:
Weight Loss and Treatment Patterns in a Real World Population of Adults Receiving Saxenda® for Weight Management in Routine Clinical Practice in Switzerland

Status Completed

Clinical Trial Summary

The study is investigating weight loss and treatment patterns associated with the use of Saxenda® in adult patients. The aim of the study is to assess the weight loss associated with Saxenda® in patients with obesity or overweight. Saxenda® was prescribed to participants by study doctor independently of this study. The study will last for about 4 months, where the data will be collected from the available medical records. There will be no additional activities expected from participants in the scope of study because it is a chart-review study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05153590
Study type	Observational
Source	Novo Nordisk A/S
Contact
Status	Completed
Phase
Start date	December 3, 2021
Completion date	April 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03629301` - Obesity Treatment Using an Internet-delivered Intervention Based on the Diabetes Prevention Program in Mexican Adults	N/A
Completed	`NCT05607680` - A Study of IBI362 in Participants With Obesity or Overweight	Phase 3
Recruiting	`NCT05996848` - A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight	Phase 3
Recruiting	`NCT05813925` - A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight	Phase 3